top of page

family on a walk hero image 3.jpg

News & Events

June 3, 2024

RS Oncology Announces Positive Data from a Phase 1 Clinical Trial of RSO-021, a First-in-Class Therapeutic for Malignant Pleural Mesothelioma

May 1, 2024

RS Oncology Data for Novel Treatment of Aggressive Cancers Selected for an Oral Presentation at ASCO Annual Meeting

March 29, 2024

RS Oncology to present translational data identifying potential biomarkers associated with RSO-021 anticancer activity

March 4, 2024

Recent advancements in treating malignant pleural mesothelioma and why localized treatment could be advantageous

rso footer (1) copy.webp

bottom of page